Product description
Brand name
COMIRNATY that has been approved recently by Health Canada
Company name
BioNTech Manufacturing GmbH
Ingredient
mRNA encoding SARS-CoV-2 spike protein, 5’ [m27,3’-OGppp(m12’-O)ApG] cap, 110-nucleotide 3′ poly(A) tail with a 10-nucleotide linker sequence.
This product (COMIRNATY) includes an update to the antigen composition (variant Omicron KP.2) and replaces COMIRNATY Omicron XBB.1.5 (raxtozinameran).